Literature DB >> 9198053

Comparison of lactate and bicarbonate buffered haemofiltration fluids: use in critically ill patients.

A N Thomas1, J M Guy, R Kishen, I F Geraghty, B J Bowles, P Vadgama.   

Abstract

OBJECTIVE: To compare acid-base balance, lactate concentration, and haemodynamic and O2 transport variables during haemofiltration with replacement fluid containing 44.5 mmol/l Na+ lactate or 40 mmol/l Na+ HCO3- and 3 mmol/l lactic acid.
DESIGN: A prospective, randomized trial.
SETTING: A multidisciplinary, adult intensive care unit in a university hospital. PATIENTS: Forty acidotic patients who required haemofiltration, were dependent on mechanical ventilation, and had PA catheters in situ.
INTERVENTIONS: During haemofiltration patients received lactate or bicarbonate replacement fluid at a mean rate of 1.7 l/h (SD 0.3). Arterial blood gases, plasma lactate, and haemodynamic and O2 transport variables were measured before and after 12 and 24 h haemofiltration. Ultrafiltrate was collected for lactate estimation.
MEASUREMENTS AND MAIN RESULTS: As means (SD). The net gain of lactate was 63 mmol/h (12 mmol) with Na+ lactate and 0 mmol/h (0.3 mmol) with Na+ HCO3-. There was a significant increase in pH and [lactate] in both groups, but [lactate] was higher in patients receiving lactate. Twenty-one patients survived to ICU discharge, these patients were significantly less acidotic after filtration (lactate group: 0 h: pH 7.23 (0.09), [lactate] 2.4 mmol/l (1.7); 12 h: pH 7.34 (0.09), [lactate] 4.7 mmol/l (2.4); 24 h: pH 7.36 (0.07), [lactate] 4.7 mmol (2.7). HCO3 group: 0 h: pH 7.23 (0.09), [lactate] 2.3 (1.3); 12 h: pH 7.32 (0.06), [lactate] 2.9 mmol/l (1.8); 24 h: pH 7.35 (0.08), [lactate] 2.8 mmol/l (2.0). Base deficit: survivors: 0 h: 9 mmol/l (4); 12 h: 2 mmol/l (3). Non-survivors: 0 h: 10 mmol/l (3); 12 h: 6 mmol/l (3)). Haemodynamic and O2 transport variables were not significantly affected by treatment group or outcome.
CONCLUSIONS: The degree of correction of acidosis during the first 24 h of haemofiltration was determined by patients outcome but was not affected by the substitution of bicarbonate- for lactate-containing replacement fluids.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9198053     DOI: 10.1093/ndt/12.6.1212

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

1.  The impact of lactate-buffered high-volume hemofiltration on acid-base balance.

Authors:  Louise Cole; Rinaldo Bellomo; Ian Baldwin; Matthew Hayhoe; Claudio Ronco
Journal:  Intensive Care Med       Date:  2003-05-29       Impact factor: 17.440

2.  Effect of bicarbonate and lactate buffer on glucose and lactate metabolism during hemodiafiltration in patients with multiple organ failure.

Authors:  Marc-Daniel Bollmann; Jean-Pierre Revelly; Luc Tappy; Mette M Berger; Marie-Denise Schaller; Marie-Christine Cayeux; Alexandre Martinez; René-Louis Chioléro
Journal:  Intensive Care Med       Date:  2004-03-27       Impact factor: 17.440

3.  Section 5: Dialysis Interventions for Treatment of AKI.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-03

4.  The effect of bicarbonate administration via continuous venovenous hemofiltration on acid-base parameters in ventilated patients.

Authors:  Andrew S Allegretti; Jennifer E Flythe; Vinod Benda; Emily S Robinson; David M Charytan
Journal:  Biomed Res Int       Date:  2015-01-08       Impact factor: 3.411

5.  The Value of Blood Lactate Measurements in ICU: An Evaluation of the Role in the Management of Patients on Haemofiltration.

Authors:  P Holloway; S Benham; A St John
Journal:  EJIFCC       Date:  2000-12-28

6.  Renal Dysfunction in Cirrhosis: Critical Care Management.

Authors:  Akila Rajakumar; Ellango Appuswamy; Ilankumaran Kaliamoorthy; Mohamed Rela
Journal:  Indian J Crit Care Med       Date:  2021-02

Review 7.  Bench-to-bedside review: lactate and the kidney.

Authors:  Rinaldo Bellomo
Journal:  Crit Care       Date:  2002-06-07       Impact factor: 9.097

Review 8.  Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit--the role of renal replacement therapy.

Authors:  Toshio Naka; Rinaldo Bellomo
Journal:  Crit Care       Date:  2004-02-17       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.